Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1996 1
1997 1
2001 1
2003 1
2004 1
2006 1
2009 1
2010 2
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Zinc lozenges as cure for the common cold--a review and hypothesis.
Eby GA 3rd. Eby GA 3rd. Med Hypotheses. 2010 Mar;74(3):482-92. doi: 10.1016/j.mehy.2009.10.017. Epub 2009 Nov 10. Med Hypotheses. 2010. PMID: 19906491 Free PMC article. Review.
Solution equilibrium chemistry analytical techniques showed lozenge iZn fraction varying from 0% to 100% of total lozenge zinc between trials, with zinc acetate (ZA) releasing 100% iZn, zinc gluconate (ZG) releasing 72% iZn and other zinc
Solution equilibrium chemistry analytical techniques showed lozenge iZn fraction varying from 0% to 100% of total lozenge z
Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study.
Eby GA, Davis DR, Halcomb WW. Eby GA, et al. Antimicrob Agents Chemother. 1984 Jan;25(1):20-4. doi: 10.1128/aac.25.1.20. Antimicrob Agents Chemother. 1984. PMID: 6367635 Free PMC article. Clinical Trial.
As a possible treatment for common colds, we tested zinc gluconate lozenges in a double-blind, placebo-controlled, clinical trial. One 23-mg zinc lozenge or matched placebo was dissolved in the mouth every 2 wakeful h after an initial double dose. ...
As a possible treatment for common colds, we tested zinc gluconate lozenges in a double-blind, placebo-controlled, clinical tr …
Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: a double-blind, placebo-controlled clinical trial.
Eby GA, Halcomb WW. Eby GA, et al. Altern Ther Health Med. 2006 Jan-Feb;12(1):34-8. Altern Ther Health Med. 2006. PMID: 16454145 Clinical Trial.
OBJECTIVE: To improve results using a zinc gluconate nasal spray with zinc orotate lozenges. DESIGN: Double-blind, placebo-controlled clinical trial. ...We found no reason to recommend intranasal zinc gluconate or zinc orotate lozenges in …
OBJECTIVE: To improve results using a zinc gluconate nasal spray with zinc orotate lozenges. DESIGN: Double-blind, plac …
Zinc lozenges as cure for common colds.
Eby GA. Eby GA. Ann Pharmacother. 1996 Nov;30(11):1336-8. doi: 10.1177/106002809603001120. Ann Pharmacother. 1996. PMID: 8913420 Review. No abstract available.
Zinc lozenges: cold cure or candy? Solution chemistry determinations.
Eby GA. Eby GA. Biosci Rep. 2004 Feb;24(1):23-39. doi: 10.1023/b:bire.0000037754.71063.41. Biosci Rep. 2004. PMID: 15499830 Free PMC article.
Common colds were shortened by 7 days in a 1984 clinical trial using zinc gluconate throat lozenges each 2 h. Between then and 2004, 10 other double-blind, placebo-controlled clinical trials showed widely varying results. ...Statistically significant correlation was …
Common colds were shortened by 7 days in a 1984 clinical trial using zinc gluconate throat lozenges each 2 h. Between then and …
The problem with zinc lozenges.
Eby G. Eby G. J Fam Pract. 2010 Jan;59(1):13. J Fam Pract. 2010. PMID: 20383876 No abstract available.
Zinc ion availability--the determinant of efficacy in zinc lozenge treatment of common colds.
Eby GA. Eby GA. J Antimicrob Chemother. 1997 Oct;40(4):483-93. doi: 10.1093/oxfordjournals.jac.a020864. J Antimicrob Chemother. 1997. PMID: 9372416
Lozenges that released negatively charged zinc species at physiological pH (negative ZIAs) lengthened colds. ...A linear dose-response relationship exists between ZIAs of zinc lozenges and changes in duration of common colds. It is concluded that: pros
Lozenges that released negatively charged zinc species at physiological pH (negative ZIAs) lengthened colds. ...A linear dose-
Cold-Eeze lozenge for common colds.
Eby G. Eby G. Am J Ther. 2003 May-Jun;10(3):233; author reply 233-4. doi: 10.1097/00045391-200305000-00012. Am J Ther. 2003. PMID: 12756432 No abstract available.